Benzinga | Aug 26, 2021 09:30AM EDT

Clinicaltrials.gov Site Shows Delcath Systems Study 'An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma' Available

https://clinicaltrials.gov/ct2/show/NCT05022901